Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2007
04/24/2007US7208604 Methods for the synthesis of alfentanil, sufentanil, and remifentanil
04/24/2007US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein.
04/24/2007US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
04/24/2007US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group
04/24/2007US7208500 Treating hyperproliferative disorders; N-(4,6-Dimethyl-pyridin-2-yl)-2-{3-fluoro-4-[2-(1-methyl- 1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-phenyl}-acetamide for example; receptor kinase inhibitors
04/24/2007US7208497 Substituted piperazines and diazepanes
04/24/2007US7208495 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
04/24/2007US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling
04/24/2007US7208169 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
04/24/2007CA2281545C N-heterocyclic derivatives as nos inhibitors
04/24/2007CA2281471C Process for preparing eprosartan
04/24/2007CA2197793C New multimerizing agents
04/24/2007CA2194503C 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use
04/19/2007WO2007044515A1 Azetidines as mek inhibitors for the treatment of proliferative diseases
04/19/2007WO2007043653A1 Benzimidazole-5-carboxamide derivative
04/19/2007WO2007043638A1 Condensed heterocyclic compound
04/19/2007WO2007043484A1 Carbazole-containing amine compound and use thereof
04/19/2007WO2007043457A1 Triarylcarboxylic acid derivative
04/19/2007WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007042912A2 Heterocyclic compounds as pstat3/il-6 inhibitors
04/19/2007WO2007042325A1 Antibacterial active 5-chinolin derivative
04/19/2007WO2007042321A2 Kinase inhibitors
04/19/2007WO2007041969A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof
04/19/2007WO2007006534A3 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity
04/19/2007WO2007003389A3 Substituted sulfolanyl pyrazoles and the use thereof
04/19/2007WO2006131398A3 Inhibitors of soluble adenylate cyclase
04/19/2007WO2006131340A3 Pyrrolones that act as peptide deformylase (pdf) inhibitors
04/19/2007WO2006103003A3 Substituted pyrazolyl oxyphenyl derivatives used as herbicides
04/19/2007WO2006074924A8 3,4,(5)-substituted tetrahvdropyridines
04/19/2007WO2006034317A3 Chemical compounds
04/19/2007US20070088067 Novel amidine compounds for treating microbial infections
04/19/2007US20070088064 Pharmaceutical composition containing bicyclic type compounds
04/19/2007US20070088054 Biphenyl derivatives
04/19/2007US20070088044 Quinazoline derivatives as antitumor agents
04/19/2007US20070088041 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
04/19/2007US20070088033 Diaryl Substituted Pyridinones
04/19/2007US20070088018 Cb1 antagonist compounds
04/19/2007US20070088016 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure
04/19/2007CA2625687A1 Antibacterial active 5-chinolin derivative
04/19/2007CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors
04/19/2007CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
04/19/2007CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3
04/19/2007CA2623500A1 Kinase inhibitors
04/19/2007CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007CA2622755A1 Mek inhibitors and methods of their use
04/19/2007CA2621038A1 Triarylcarboxylic acid derivative
04/18/2007EP1773868A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
04/18/2007EP1773824A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
04/18/2007EP1773822A2 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
04/18/2007EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
04/18/2007EP1773809A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
04/18/2007EP1773797A2 Aromatic compounds
04/18/2007EP1773788A2 Quinazoline derivatives
04/18/2007EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors
04/18/2007EP1773781A2 Indazoles useful in treating cardiovascular diseases
04/18/2007EP1773775A1 Six-membered heterocycles useful as serine protease inhibitors
04/18/2007EP1773768A2 Pyrrole derivatives as pharmaceutical agents
04/18/2007EP1773758A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
04/18/2007EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
04/18/2007EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
04/18/2007EP1773337A2 Modulators of nuclear receptors
04/18/2007EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
04/18/2007EP1442032B1 Heterocyclic retinoid compounds
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007EP1240161B1 Thienylalanine derivatives as inhibitors of cell adhesion
04/18/2007CN1950393A Novel inhibitors of hepatitis c virus ns3 protease
04/18/2007CN1950365A Indolyl derivatives as liver-X-receptor modulators
04/18/2007CN1950357A Imidazole derivatives used as TAFIA inhibitors
04/18/2007CN1950345A Morpholinylanilinoquinazoline derivatives for use as antiviral agents
04/18/2007CN1950337A (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease
04/18/2007CN1949966A Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof
04/18/2007CN1948304A Heteraryl ring thiosemicarbazone kind compound and its derivative
04/18/2007CN1310909C Novel heteroaryl derivatives, their prepn. and use
04/18/2007CN1310900C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same
04/17/2007USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/17/2007US7206111 Sterically hindered PI-bridge nonlinear optical chromophores, processes including same, and devices therefrom
04/17/2007US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators
04/17/2007US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide
04/17/2007US7205328 Aids viricide
04/17/2007US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders
04/17/2007US7205317 Pain management
04/17/2007US7205313 Central nervous system disorders; analgesics; headaches
04/17/2007US7205307 Pyrimidines as novel openers of potassium ion channels
04/17/2007US7205305 Inhibitors of p38
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders
04/17/2007US7205301 Microbiocidal N-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
04/17/2007US7205296 Substituted 2H-1,3-benzoxazin-4(3H)-ones
04/17/2007US7205054 Metal coordination compound, luminescence device and display apparatus
04/17/2007CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors
04/17/2007CA2299300C Arylpyridazinones as prostaglandin endoperoxide h synthase bisoynthesis inhibitors
04/17/2007CA2272882C Ketone derivatives and their medical applications
04/17/2007CA2226214C Antifungal agent, compound therefor, process for producing the same, and method for using the same
04/17/2007CA2203592C Process for the preparation of arylamides of heteroaromatic carboxylic acids
04/17/2007CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
04/12/2007WO2007041616A1 Piperazine amidines as antiviral agents
04/12/2007WO2007041324A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007WO2007041270A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007WO2007040682A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation